Lung fungal microbiome of critical COVID-19 patients

The study was aimed to characterize the lower respiratory tract mycobiome of COVID-19 critically ill patients and investigate the fungal microbiome diversity in comparison to COVID-19-negative patients. We performed ITS rRNA gene profiling, with the Illumina MiSeq platform to analyse the fungal microbiome in bronchoalveolar lavage (BAL) samples collected from COVID-19 critically ill subjects and patients with non-COVID-19 pneumonia